Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. (2025). Nigerian Journal of Physiological Sciences, 40(2), 251-262. https://doi.org/10.54548/